Siloam International Hospitals Tbk PT
F:2LS

Watchlist Manager
Siloam International Hospitals Tbk PT Logo
Siloam International Hospitals Tbk PT
F:2LS
Watchlist
Price: 0.09 EUR -1.1% Market Closed
Market Cap: €1.2B

Wall St Price Targets

2LS Price Targets Summary
Siloam International Hospitals Tbk PT

Wall Street analysts forecast 2LS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 2LS is 0.13 EUR with a low forecast of 0.11 EUR and a high forecast of 0.14 EUR.

Lowest Forecast
Price Target
0.11 EUR
19% Upside
Average Forecast
Price Target
0.13 EUR
40% Upside
Highest Forecast
Price Target
0.14 EUR
61% Upside
Siloam International Hospitals Tbk PT Competitors:
Price Targets

Revenue
Forecast

16% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
16% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 16%. The projected CAGR for the next 3 years is 10%.

Gross Profit
Forecast

20% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
20% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 20%. The projected CAGR for the next 3 years is 11%.

Operating Income
Forecast

25% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss
25% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 25%. The projected CAGR for the next 3 years is 16%.

Pre-Tax Income
Forecast

26% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
8%
Average Beat
26% / Year
Past Growth
15% / Year
Estimated Growth
Estimates Accuracy
8%
Average Beat

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 26%. The projected CAGR for the next 3 years is 15%.

Net Income
Forecast

27% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
2%
Average Beat
27% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
2%
Average Beat

Over the last 13 years, the compound annual growth rate for Net Income has been 27%. The projected CAGR for the next 3 years is 14%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 2LS's stock price target?
Price Target
0.13 EUR

According to Wall Street analysts, the average 1-year price target for 2LS is 0.13 EUR with a low forecast of 0.11 EUR and a high forecast of 0.14 EUR.

What is the Revenue forecast for Siloam International Hospitals Tbk PT?
Projected CAGR
10%

Over the last 13 years, the compound annual growth rate for Revenue has been 16%. The projected CAGR for the next 3 years is 10%.

What is the Gross Profit forecast for Siloam International Hospitals Tbk PT?
Projected CAGR
11%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 20%. The projected CAGR for the next 3 years is 11%.

What is the Operating Income forecast for Siloam International Hospitals Tbk PT?
Projected CAGR
16%

Over the last 13 years, the compound annual growth rate for Operating Income has been 25%. The projected CAGR for the next 3 years is 16%.

What is the Pre-Tax Income forecast for Siloam International Hospitals Tbk PT?
Projected CAGR
15%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 26%. The projected CAGR for the next 3 years is 15%.

What is the Net Income forecast for Siloam International Hospitals Tbk PT?
Projected CAGR
14%

Over the last 13 years, the compound annual growth rate for Net Income has been 27%. The projected CAGR for the next 3 years is 14%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett